Search Results 521-530 of 18025 for Alopecia
52 (58%) women were diagnosed with polycystic ovary syndrome (PCOS). Women with APT were more likely to have male-pattern alopecia documented on physical ...
... alopecia or other toxicities not considered a safety risk for the subject at the Investigator's discretion). 4. Subject has had major surgery within 14 days ...
... alopecia). Active uncontrolled bacterial, viral, or fungal infection requiring systemic therapy. Known history of testing positive for human ...
0) Grade -study baseline (except alopecia or neuropathy); Adequate organ function as defined by the following criteria: Serum aspartate transaminase (AST ...
... alopecia and ≤Grade 2 peripheral neuropathy. Eastern Cooperative Oncology Group (ECOG) performance score of 0 or 1 (Appendix B). Life expectancy ≥12 weeks ...
Toxicities due to prior therapy must be stable and recovered to Grade ≤ 1 (except for clinically nonsignificant toxicities such as alopecia). Age 18 or ...
All acute toxic effects (excluding alopecia) of any prior therapy must have resolved to National Cancer Institute (NCI) Common Terminology Criteria for Adverse ...
Complete resolution of toxic effect(s) of the most recent prior chemotherapy to Grade 1 or less (except alopecia). If the subject received major surgery or ...
Recovery to ≤ Grade 1 or baseline of any toxicities due to prior systemic treatments, excluding alopecia;; Women of child bearing potential (WCBP), defined ...
EXCEPTIONS: Stable chronic conditions (≤ grade 2) that are not expected to resolve (such as neuropathy, myalgia, alopecia, prior therapy-related ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.